TriSalus Life Sciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TLSI Nasdaq 2836 trisaluslifesci.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc. (TLSI) Upgraded to Buy: Here's What You Should Know - Jan 14th, 2026 10:00 am
TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance - Jan 12th, 2026 5:00 am
3 Growth Companies With High Insider Ownership Achieving 29% Revenue Growth - Dec 10th, 2025 10:35 am
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025 - Dec 4th, 2025 2:01 pm
TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™ - Nov 18th, 2025 6:00 am
TriSalus Life Sciences Inc (TLSI) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ... - Nov 13th, 2025 10:04 pm
TriSalus (TLSI) Q3 2025 Earnings Call Transcript - Nov 13th, 2025 3:34 pm
TriSalus Life Sciences, Inc. (TLSI) Reports Q3 Loss, Tops Revenue Estimates - Nov 13th, 2025 3:15 pm
TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance - Nov 13th, 2025 2:01 pm
Rockwell Medical (RMTI) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 5:10 am
TriSalus Life Sciences to Participate in Upcoming Investor Conferences - Nov 11th, 2025 2:05 pm
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025 - Nov 10th, 2025 6:00 am
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates - Nov 6th, 2025 5:00 pm
biote Corp. (BTMD) Tops Q3 Earnings and Revenue Estimates - Nov 5th, 2025 4:15 pm
TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call - Oct 30th, 2025 6:00 am
TriSalus Life Sciences to Participate in Upcoming September Investor Conferences - Aug 28th, 2025 6:00 am
TriSalus Life Sciences Inc (TLSI) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... - Aug 13th, 2025 1:12 am
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates - Aug 12th, 2025 3:10 pm
TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance - Aug 12th, 2025 2:01 pm
TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique - Aug 11th, 2025 6:00 am